Skip to content

Optilite IgG3 LK008.OPT.A

by The Binding Site Group

Optilite IgG3 LK008.OPT.A is a Class II device made by The Binding Site Group, cleared under FDA 510(k) K142735 on 21 Dec 2014 and listed in FDA GUDID since 24 Sep 2016 (UDI-DI 05051700017541), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K142735

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number05051700017541 UDI-DI Date24 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k) from GUDID NumberK142735 Date21 Dec 2014IssuedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K142735 decided 21 Dec 2014 Active
  • FDA GUDID UDI-DI 05051700017541 listed 24 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K142735
  2. Listed FDA GUDID 05051700017541

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Optilite IgG3
Generic name
Immunoglobulin G subclass (IgG subclass) IVD, kit, nephelometry/turbidimetry
Model / reference
LK008.OPT.A
Primary DI / UDI-DI
05051700017541
510(k) Number
FDA product code
CFN
GMDN term
Immunoglobulin G subclass (IgG subclass) IVD, kit, nephelometry/turbidimetry
Device class
Class II
Regulation number
866.5510
GUDID distribution status
In Commercial Distribution

Other devices from The Binding Site Group

See all devices from The Binding Site Group →

Properties

  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)